These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35259710)

  • 1. NK cells - Dr. Jekyll and Mr. Hyde in autoimmune rheumatic diseases.
    Hojjatipour T; Aslani S; Salimifard S; Mikaeili H; Hemmatzadeh M; Gholizadeh Navashenaq J; Ahangar Parvin E; Jadidi-Niaragh F; Mohammadi H
    Int Immunopharmacol; 2022 Jun; 107():108682. PubMed ID: 35259710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Natural Killer Cells in Autoimmune Diseases.
    Kucuksezer UC; Aktas Cetin E; Esen F; Tahrali I; Akdeniz N; Gelmez MY; Deniz G
    Front Immunol; 2021; 12():622306. PubMed ID: 33717125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.
    Park YW; Kee SJ; Cho YN; Lee EH; Lee HY; Kim EM; Shin MH; Park JJ; Kim TJ; Lee SS; Yoo DH; Kang HS
    Arthritis Rheum; 2009 Jun; 60(6):1753-63. PubMed ID: 19479851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping.
    Tanaka H; Okada Y; Nakayamada S; Miyazaki Y; Sonehara K; Namba S; Honda S; Shirai Y; Yamamoto K; Kubo S; Ikari K; Harigai M; Sonomoto K; Tanaka Y
    Ann Rheum Dis; 2024 Jan; 83(2):242-252. PubMed ID: 37903543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered circadian rhythms of natural killer (NK) cell activity in patients with autoimmune rheumatic diseases.
    Masera RG; Carignola R; Staurenghi AH; Sartori ML; Lazzero A; Griot G; Angeli A
    Chronobiologia; 1994; 21(1-2):127-32. PubMed ID: 7924633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?
    Gianchecchi E; Delfino DV; Fierabracci A
    Front Immunol; 2021; 12():616853. PubMed ID: 33679757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of activated T cell survival in rheumatic autoimmune diseases.
    Rosetti F; Madera-Salcedo IK; Rodríguez-Rodríguez N; Crispín JC
    Nat Rev Rheumatol; 2022 Apr; 18(4):232-244. PubMed ID: 35075294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus.
    Schepis D; Gunnarsson I; Eloranta ML; Lampa J; Jacobson SH; Kärre K; Berg L
    Immunology; 2009 Jan; 126(1):140-6. PubMed ID: 18564343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases.
    Lisitsyna TA; Veltishchev DY; Seravina OF; Kovalevskaya OB; Starovoytova MN; Desinova OV; Abramkin AA; Ovcharov PS; Vasil'ev VI; Alekberova ZS; Krasnov VN; Nasonov EL
    Ter Arkh; 2018 May; 90(5):30-37. PubMed ID: 30701894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage: Key player in the pathogenesis of autoimmune diseases.
    Yang S; Zhao M; Jia S
    Front Immunol; 2023; 14():1080310. PubMed ID: 36865559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis.
    Neighbour PA; Grayzel AI; Miller AE
    Clin Exp Immunol; 1982 Jul; 49(1):11-21. PubMed ID: 6181920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?
    Kato M; Yasuda S; Atsumi T
    Rheumatol Int; 2018 Aug; 38(8):1333-1338. PubMed ID: 29623390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells and autoimmunity.
    Grunebaum E; Malatzky-Goshen E; Shoenfeld Y
    Immunol Res; 1989; 8(4):292-304. PubMed ID: 2687403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells in human autoimmune disorders.
    Fogel LA; Yokoyama WM; French AR
    Arthritis Res Ther; 2013 Jul; 15(4):216. PubMed ID: 23856014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK Cells in Autoimmune Diseases: Protective or Pathogenic?
    Liu M; Liang S; Zhang C
    Front Immunol; 2021; 12():624687. PubMed ID: 33777006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras family signaling pathway in immunopathogenesis of inflammatory rheumatic diseases.
    Sadeghi Shaker M; Rokni M; Mahmoudi M; Farhadi E
    Front Immunol; 2023; 14():1151246. PubMed ID: 37256120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells in inflammatory autoimmune diseases.
    Yang Y; Day J; Souza-Fonseca Guimaraes F; Wicks IP; Louis C
    Clin Transl Immunology; 2021; 10(2):e1250. PubMed ID: 33552511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells in connective tissue disorders.
    Sibbitt WL; Bankhurst AD
    Clin Rheum Dis; 1985 Dec; 11(3):507-21. PubMed ID: 3907953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases.
    Kojo S; Adachi Y; Keino H; Taniguchi M; Sumida T
    Arthritis Rheum; 2001 May; 44(5):1127-38. PubMed ID: 11352245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease?
    Wenink MH; Leijten EFA; Cupedo T; Radstake TRDJ
    Arthritis Rheumatol; 2017 May; 69(5):885-897. PubMed ID: 28217945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.